You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

untreated childhood anaplastic oligodendroglioma

Showing 1 - 25 of 6,030
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
Has Results
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Childhood Brain Tumors Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Completed
Has Results
  • Childhood Brain Tumors
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Mar 3, 2022

NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Matching Placebo)

Recruiting
  • Non-Small Cell Lung Cancer
  • Littleton, Colorado
  • +175 more
Jan 12, 2023

Early Childhood Caries Trial in Alexandria (SDF, NaF)

Active, not recruiting
  • Early Childhood Caries
  • SDF
  • NaF
  • Alexandria, Egypt
    Faculty Of Dentistry Alexandria University
Nov 29, 2022

Oligodendroglioma, Adult Trial in Philadelphia (Abemaciclib 200 MG)

Active, not recruiting
  • Oligodendroglioma, Adult
  • Abemaciclib 200 MG
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2022

CNS Cancer, CNS BRAIN Trial in Basking Ridge, Commack, New York (temozolomide followed by high dose busulfan and thiotepa)

Active, not recruiting
  • CNS Cancer
  • CNS BRAIN
  • temozolomide followed by high dose busulfan and thiotepa
  • Basking Ridge, New Jersey
  • +2 more
Oct 7, 2021

Rare CNS Tumors Outcomes &Risk

Recruiting
  • High Grade Meningioma
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

    Completed
    • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
    • +76 more
    • fludarabine phosphate
    • +6 more
    • Tucson, Arizona
    • +10 more
    Jan 17, 2020

    Trends in Anaplastic Thyroid Cancer Patients' Clinical Study

    Not yet recruiting
    • Anaplastic Thyroid Cancer
      • (no location specified)
      Apr 6, 2023

      Familial Hypercholesterolemia Trial

      Not yet recruiting
      • Familial Hypercholesterolemia
        • (no location specified)
        Apr 11, 2023

        Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

        Active, not recruiting
        • Anaplastic Astrocytoma
        • +6 more
        • Laboratory Biomarker Analysis
        • +4 more
        • Los Angeles, California
        • +11 more
        Jul 1, 2022

        Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

        Not yet recruiting
        • Lung Cancer
        • Non-small Cell Lung Cancer
        • (no location specified)
        Jul 7, 2023

        Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)

        Completed
        Has Results
        • Anaplastic Astrocytoma
        • +12 more
        • 3-Dimensional Conformal Radiation Therapy
        • +5 more
        • Los Angeles, California
        • +11 more
        Jul 17, 2019

        Anaplastic Thyroid Cancer Trial in Japan (Lenvatinib, Nivolumab)

        Recruiting
        • Anaplastic Thyroid Cancer
        • Nagoya, Aichi, Japan
        • +9 more
        Jan 13, 2023

        Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

        Active, not recruiting
        • Thyroid Cancer
        • +2 more
        • Stanford, California
          Stanford University
        Nov 8, 2022

        Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

        Recruiting
        • Thyroid Cancer
        • Chengdu, Sichuan, China
          Xingchen Peng
        Dec 17, 2022

        University Students, Childhood Traumas, Emotional Intelligence Trial in Üsküdar (Survey work)

        Completed
        • University Students
        • +2 more
        • Survey work
        • Üsküdar, İstanbul, Turkey
          Health Sciences University Sultan 2. Abdulhamid Han Training and
        Apr 26, 2023

        Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

        Recruiting
        • Thyroid Cancer
        • Basking Ridge, New Jersey
        • +6 more
        Aug 17, 2023

        NSCLC Trial in Germany (Brigatinib, Tyrosine kinase inhibitor)

        Recruiting
        • NSCLC
        • Berlin, Germany
        • +25 more
        Nov 10, 2022

        Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

        Not yet recruiting
        • Uveal Melanoma
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Oct 5, 2023

        Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)

        Not yet recruiting
        • Astrocytoma
        • +2 more
        • Craniotomy
        • Quantitative Oblique Back-Illumination Microscopy
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Aug 22, 2022

        Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

        Not yet recruiting
        • Thyroid Cancer
        • 20 mg Famitinib & 1200 mg Adebrelimab
        • (no location specified)
        Nov 26, 2023